Balaxi Pharmaceuticals Ltd (BALX)

Currency in INR
47.50
+0.30(+0.64%)
Real-time Data·

BALX Financial Summary

Key Ratios

P/E Ratio10.29
Price/Book1.11
Debt / Equity23.05%
Return on Equity11.58%
Dividend Yield0.00%
EBITDA370.30M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
May 30, 2025
EPS / Forecast
1.56 / --
Revenue / Forecast
745.73M / --
EPS Revisions
Last 90 days

FAQ

What were Balaxi Pharmaceuticals's earnings for the latest quarter?

The Balaxi Pharmaceuticals EPS (TTM) is 4.54. Balaxi Pharmaceuticals reported sales of 762.66, net income of 86.38, and EPS of 1.56 for the latest quarter.

What was Balaxi Pharmaceuticals's net income for the latest quarter?

Balaxi Pharmaceuticals's net income for the latest quarter was 86.38.

How did Balaxi Pharmaceuticals's performance compare year-over-year in the latest quarter?

The company's revenue moved from 732.91 in the previous quarter to 762.66 in the latest quarter, and net income moved from 53.63 to 86.38 compared to the previous quarter.

What is Balaxi Pharmaceuticals's net profit margin on a TTM basis?

Balaxi Pharmaceuticals's trailing twelve months (TTM) net profit margin is 8.57%.

How does Balaxi Pharmaceuticals's debt to equity ratio compare to industry standards?

Balaxi Pharmaceuticals's total debt-to-equity ratio is 23.05%.

What is Balaxi Pharmaceuticals's return on investment on a TTM basis?

Balaxi Pharmaceuticals's trailing twelve months (TTM) return on investment (ROI) is 11.58%.

What were Balaxi Pharmaceuticals's total assets and liabilities in the latest quarter?

As of the latest quarter, Balaxi Pharmaceuticals reported total assets of 3,103.42 million and total liabilities of 545.32 million.

How has Balaxi Pharmaceuticals's total revenue grown this year?

Balaxi Pharmaceuticals's total revenue was 732.91 in the previous quarter and 762.66 in the latest quarter.

What is Balaxi Pharmaceuticals's gross margin on a TTM basis?

Balaxi Pharmaceuticals's trailing twelve months (TTM) gross margin is 43.28%.

What was Balaxi Pharmaceuticals's revenue per share for the latest quarter?

Balaxi Pharmaceuticals's revenue per share for the latest quarter was 299.13.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.